ImmuCell ROA 2010-2025 | ICCC
Current and historical return on assets (ROA) values for ImmuCell (ICCC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ImmuCell ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.00B | $0.05B | -2.26% |
| 2024-12-31 | $0.00B | $0.05B | -4.60% |
| 2024-09-30 | $0.00B | $0.04B | -9.25% |
| 2024-06-30 | $0.00B | $0.04B | -9.20% |
| 2024-03-31 | $0.00B | $0.04B | -6.82% |
| 2023-12-31 | $-0.01B | $0.04B | -11.36% |
| 2023-09-30 | $-0.01B | $0.05B | -13.56% |
| 2023-06-30 | $-0.01B | $0.04B | -13.48% |
| 2023-03-31 | $-0.01B | $0.04B | -13.33% |
| 2022-12-31 | $0.00B | $0.05B | -6.52% |
| 2022-09-30 | $0.00B | $0.05B | -2.19% |
| 2022-06-30 | $0.00B | $0.05B | 0.00% |
| 2022-03-31 | $0.00B | $0.05B | 2.23% |
| 2021-12-31 | $0.00B | $0.04B | 0.00% |
| 2021-09-30 | $0.00B | $0.04B | 0.00% |
| 2021-06-30 | $0.00B | $0.04B | 0.00% |
| 2021-03-31 | $0.00B | $0.04B | -2.48% |
| 2020-12-31 | $0.00B | $0.04B | -2.48% |
| 2020-09-30 | $0.00B | $0.04B | -2.50% |
| 2020-06-30 | $0.00B | $0.04B | -5.03% |
| 2020-03-31 | $0.00B | $0.04B | -5.10% |
| 2019-12-31 | $0.00B | $0.04B | -5.10% |
| 2019-09-30 | $0.00B | $0.04B | -7.95% |
| 2019-06-30 | $0.00B | $0.04B | -5.52% |
| 2019-03-31 | $0.00B | $0.04B | -5.76% |
| 2018-12-31 | $0.00B | $0.03B | -6.02% |
| 2018-09-30 | $0.00B | $0.03B | -2.99% |
| 2018-06-30 | $0.00B | $0.03B | -3.05% |
| 2018-03-31 | $0.00B | $0.03B | 0.00% |
| 2017-12-31 | $0.00B | $0.03B | 3.42% |
| 2017-09-30 | $0.00B | $0.03B | 3.70% |
| 2017-06-30 | $0.00B | $0.03B | 4.04% |
| 2017-03-31 | $0.00B | $0.03B | 4.35% |
| 2016-12-31 | $0.00B | $0.03B | 0.00% |
| 2016-09-30 | $0.00B | $0.02B | 0.00% |
| 2016-06-30 | $0.00B | $0.02B | 0.00% |
| 2016-03-31 | $0.00B | $0.02B | 0.00% |
| 2015-12-31 | $0.00B | $0.02B | 0.00% |
| 2015-09-30 | $0.00B | $0.01B | 0.00% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $0.00B | $0.01B | 0.00% |
| 2014-12-31 | $0.00B | $0.01B | 0.00% |
| 2014-09-30 | $0.00B | $0.01B | 0.00% |
| 2014-06-30 | $0.00B | $0.01B | 0.00% |
| 2014-03-31 | $0.00B | $0.01B | 0.00% |
| 2013-12-31 | $0.00B | $0.01B | 0.00% |
| 2013-09-30 | $0.00B | $0.01B | 0.00% |
| 2013-06-30 | $0.00B | $0.01B | 0.00% |
| 2013-03-31 | $0.00B | $0.01B | 0.00% |
| 2012-12-31 | $0.00B | $0.01B | 0.00% |
| 2012-09-30 | $0.00B | $0.01B | 0.00% |
| 2012-06-30 | $0.00B | $0.01B | 0.00% |
| 2012-03-31 | $0.00B | $0.01B | 0.00% |
| 2011-12-31 | $0.00B | $0.01B | 0.00% |
| 2011-09-30 | $0.00B | $0.01B | 0.00% |
| 2011-06-30 | $0.00B | $0.01B | 0.00% |
| 2011-03-31 | $0.00B | $0.01B | 0.00% |
| 2010-12-31 | $0.00B | $0.01B | 0.00% |
| 2010-09-30 | $0.00B | $0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.01B | 0.00% |
| 2009-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.055B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
| Boston Scientific (BSX) | United States | $152.872B | 36.46 |
| Stryker (SYK) | United States | $146.007B | 29.72 |
| EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
| Medtronic (MDT) | Ireland | $119.234B | 16.91 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.347B | 24.74 |
| ResMed (RMD) | United States | $41.712B | 29.83 |
| Agilent Technologies (A) | United States | $33.861B | 22.07 |
| GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
| Insulet (PODD) | United States | $22.615B | 75.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
| Baxter (BAX) | United States | $12.419B | 9.60 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
| Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
| ICU Medical (ICUI) | United States | $2.986B | 20.33 |
| Haemonetics (HAE) | United States | $2.589B | 11.56 |
| LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
| Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
| AtriCure (ATRC) | United States | $1.762B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.761B | 11.08 |
| Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
| AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
| Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
| Acuren (TIC) | United States | $1.190B | 0.00 |
| Neogen (NEOG) | United States | $1.179B | 18.72 |
| BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
| Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
| Valneva SE (VALN) | France | $0.981B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 8.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
| Surmodics (SRDX) | United States | $0.536B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
| CeriBell (CBLL) | United States | $0.451B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
| Owens & Minor (OMI) | United States | $0.439B | 3.89 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.435B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
| Omeros (OMER) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 49.92 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.212B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 19.20 |
| Biote (BTMD) | United States | $0.144B | 4.79 |
| Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.08 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.05 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |